Galmed Pharmaceuticals Ltd
GLMD
Loading quote...
Financials
| 52Week High | 23.80 | 52Week Low | 1.15 |
| Beta | 0.43 | Current Ratio Annual | 7.42 |
| Current Ratio Quarterly | 9.02 | Market Cap | 3.27M |
| Net Profit Margin TTM | -424.24 | Operating Margin TTM | -439.83 |
| Price To Book | 0.19 | Price To Sales TTM | 1.42 |
| Quick Ratio Annual | 7.21 | Quick Ratio Quarterly | 9.02 |
| Return On Assets TTM | -41.31 | Return On Equity TTM | -46.18 |
| Return On Investment TTM | -46.18 | Revenue Per Share TTM | 0.00 |
13F Aggregates
| Quarter | Funds | Added | Exited | Increased | Decreased | Unchanged | Shares | Value |
|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 13 | 1 | 0 | 1 | 0 | 0 | 44.78K | $142.81K |
| Mar 31, 2025 | 14(+8%) | 2(+100%) | 0 | 0(-100%) | 4(+%) | 7(+%) | 55.89K(+25%) | $64.45K(-55%) |
| Jun 30, 2025 | 15(+7%) | 4(+100%) | 2(+%) | 2(+%) | 1(-75%) | 7 | 42.43K(-24%) | $59.42K(-8%) |